Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy

PURPOSE: To report the clinical course of a woman treated with intravitreal bevacizumab during pregnancy. CASE REPORT: A 27-year-old female with poorly controlled diabetes and a history of two previous miscarriage was referred to our hospital with sudden deterioration in visual acuity (VA) in her ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kianersi, Farzan, Ghanbari, Heshmatollah, Naderi Beni, Zahra, Naderi Beni, Afsaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Pregnancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971320/
https://www.ncbi.nlm.nih.gov/pubmed/33796345
http://dx.doi.org/10.1080/21556660.2020.1847926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971320/
https://www.ncbi.nlm.nih.gov/pubmed/33796345
http://dx.doi.org/10.1080/21556660.2020.1847926

Ejemplares similares